For over 125 years globally, and for 25 years here in the country, MSD in the Philippines has
been researching and developing medicines and vaccines for many of the world’s most
challenging diseases. With unwavering focus, MSD looks for medical innovations that improve
health and save lives throughout the world. At the heart of MSD’s success is its strong Human
Resource (HR) team.

Through the years, MSD positioned itself as a company that focuses on leadership and culture to
drive breakthrough healthcare innovations and business success.

“Patients first”, said Marese de Vera, HR Leader. “All our actions must be measured against our
responsibility to those who use or need our products.”

The way MSD operates is based on four pillars: Patient First, Ethics and Integrity, Respect for
People, Innovation and Excellence. With these, MSD leads a conscious effort to be a company
worthy of trust by its employees and patients.

“MSD is focused on protecting the safety of its employees and their families, ensuring that our
supply of medicines and vaccines reach our patients and customers”, Mike Blanch, Corporate
Affairs Director, remarked. “We are also supporting healthcare providers, through the PHAP
Cares foundation, to make sure our frontliners are adequately equipped and protected from this
pandemic.”

Leading the fight against COVID-19

When the global pandemic escalated back in March, the government placed Metro Manila and
the whole island of Luzon under enhanced community quarantine. Several employees were
affected, fearing that they might lose their jobs along the way. MSD HR responded to address
this anxiety and fear in order for the organization to continue its operations.

Constant communication is key. “We made sure, throughout this pandemic, that we addressed
not just the physical health but the mental health of employees as well”, de Vera noted.

As a leader in the pharmaceutical industry, MSD is currently exploring multiple pathways to
advance understanding of SARS-CoV-2 and develop vaccines and treatments, including two
COVID-19 vaccine development efforts, a research collaboration to develop a novel antiviral
candidate, and an expansive internal research program to assess available vaccine and antiviral
candidates.

With the company’s experience in HIV and Ebola, MSD knows that innovation, science, and
collaboration are both essential to develop medicines and vaccines in a global public health
emergency like COVID-19. The path to vaccine development is not easy but MSD is optimistic
that collaborative spirit of the industry will yield new tools to fight coronavirus.

The culture of innovation

“Inventing for Life”, MSD’s battlecry, guides the culture of innovation that pervades across the
organization. To continually enable its pool of talent to deliver scientific breakthroughs and
health solutions that impact as many patients as possible, MSD takes a unique approach in
people management.

Innovation manifests in the company’s robust values-based HR practices – from recruitment,
onboarding, talent development, and continuous learning and leadership development.

According to de Vera, MSD ensures that employees are enabled with the knowledge, tools, and
environment that allow for innovation and creativity in the workplace. Every employee is
encouraged to always push the boundaries of what they can do for patients – while at all times
upholding ethics and integrity.

Innovation also empowered employees during the COVID-19 pandemic. The leadership
management made a call to allow work-from-home and provided employees with tools,
applications, and equipment to make remote work a success.

“We empower them, encourage them to learn, open networks up to them, encourage sharing,
and encourage experimentation with new ideas and approaches”, de Vera highlighted.

This was possible through MSD’s “Ways of Working”. Employees are empowered to make
appropriate decisions within their jurisdictions and encouraged to be forward-looking and be
open to changes, to explore different roles and functions to reach their potential. As part of
MSD’s 25th anniversary, the “Boost Up Program” will be introduced to open more opportunities
for employees to grow their career within the organization.

Prior to the pandemic, HR held various communication efforts to reach out to employees. These
are: engaged leadership or Kapihan, an intimate group breakfast session where employees
raise any question under the sun; Country Leadership Team Ikot or CLT IKOT; and, an
employee engagement pulse survey done biannually.

During the pandemic, these efforts are replaced with regular town hall meetings and daily
check-in calls done through video conferences. The goal is to reassure the employees and
ensure that the company is with them in this fight.

As a company dedicated to saving and improving lives, MSD recognizes that they have a
special responsibility to help. Innovation plays a vital role in achieving this mission.

“Over the last 25 year here in the Philippines, MSD has pushed the boundaries of science with
the hope and expectation that advancing scientific knowledge will lead to major advances in
health”, Blanch shared.

Through innovations and collaborations, MSD successfully developed and launched the first
vaccines for measles and mumps, and the first vaccine for HPV that causes cervical and other
cancers. The company also led the development of ground-breaking medicines for heart
disease, osteoporosis, diabetes, tuberculosis, HIV and melanoma. This success is not achieved
single-handedly. MSD recognized the relationships established from working with healthcare
professionals, partners, and the government, with the aim of delivering quality healthcare for the
Filipino.

Transformational leadership in action

MSD advocates transformational leadership in order to build and nurture a culture of innovation.
Programs such as MSD Fellowship Global for Health, a three-month, field-based corporate pro
bono program designed to leverage the skills and talents of our employees worldwide, help
empower leaders and develop potential leaders within the organization.

The move from a traditional office setup to a semi-open space also encouraged employees to
break barriers, communicate openly, and think creatively.

“The fact that our workplace is set for the future in that it is conducive for collaboration, agile,
innovative helps us stay ahead. This drives the sustainability of the organization”, de Vera
shared.

MSD is mission-focused on helping save and improve lives of the Filipino people. As such, the
organization continues to create an environment of mutual respect, inclusion, creativity and
accountability. With innovation and collaboration, challenges can be overcome.

Against a backdrop of unprecedented health crisis, societal shifts, and global economic uncertainty, a foundational value stands out. That is empathy.

Empathy, which is the ability to experience and relate to the thoughts, emotions, or experience of others, is all the more essential to enabling any organization to survive in the midst of a pandemic. It fosters connectedness, concern, and effective collaboration among teams –despite the physical distance.

But with or without pandemic, understanding other people’s emotions is a key skill in the workplace. It can enable us to resolve conflicts, strengthen commitment to our profession, and to improve our relationships with co-workers, partners, and customers.

For healthcare company, MSD in the Philippines, demonstrating empathy takes root from its values, and permeates as part of its culture. In an interview with Marese de Vera, MSD Human Resource Leader, and Mike Blanch, MSD Market Access and Corporate Affairs Director, we explore exemplary approaches to fostering empathy in the organization and why it drives engagement and innovation.

Defining empathy at MSD

“Empathy plays a big role in how we look after our employees, their families and the patients that we serve. Our leaders and employees have empathy or malasakit sa kapwa. This is the driving force for our employees to help those in need, and to make a difference in all our patients’ lives,” said Ms. de Vera.

Empathy enables MSD to attend to their employees’ evolving needs. In return, MSD employees are able to take care of their families, serve their clients and support their community. They are able to thrive despite unprecedented challenges.

Listening is key

“The stance of the whole organization is to listen first. And that’s where empathy starts. The only way to find solution is by listening first”, related Mr. Blanch. By listening, MSD demonstrates meaningful connection with patients and patient advocates worldwide.

During the pandemic, MSD actively listened to the needs of its employees through daily check-ins, team meetings, and virtual town hall meetings with the Managing Director, where employees get updates about the COVID-19 situation, guidance on business operations, and employee support. At the end of these sessions, employees are invited to raise questions or concerns, and get responses from the country leadership team. The company also conducted surveys to better understand and manage new employee concerns such as connectivity issues, challenges for employees whose children suddenly shifted to homeschooling or distance learning. These surveys aided the company to come up with the right initiatives to address their employees’ needs.

MSD values the perspectives of their employees. By actively listening, the company was able to create a diverse workforce and nurture a sense of belonging. Employees are comfortable to express their ideas and concerns.

“When our employees know they are crucial to our mission, not only will they thrive, but our company will, too,” Ms. de Vera added.

Helping employees navigate uncertainties

On top of adapting to the sudden shift from face-to-face work to remote and digital workplace, the pandemic brought uncertainties in terms of health and wellness, safety, finances and job security. All of these things affected the wellbeing of employees.

Christine Zuñiga, Innovative Customer Solutions Lead, shared how MSD helped employees transition by ensuring that no one is left behind.

“Our leaders asked us to support and hold the hands of our colleagues – especially in terms of how we can transition seamlessly to our digital channels and tools.” said Ms. Zuniga.

From a manager’s point-of-view, Anna Lisa Cordial, Senior District Manager, noted that achieving targets became challenging. For 21 years, she has been used to personal interactions in the field. Due to the pandemic, from personally interacting with team members and clients, to doing collaborations remotely, her team faced challenges to deliver as usual.

“MSD has always emphasized work-life balance to avoid digital burnout. The company initiated activities that aim to support its people and improve engagement with customers”, shared Ms. Cordial. “I made a conscious effort to reach out to my team and our customers. I tried to put myself in their shoes and see the situation from their perspective.”

Understanding employees’ needs

Employees appreciate how MSD has shown compassion when they experienced personal struggles regardless of their tenure.

Ms. Zuñiga related how MSD leaders and colleagues showered her with much support and encouragement during her personal COVID-19 battle.

“The kindness and empathy I received during that difficult period extinguished my fears and anxieties. When someone is kind to you, you want to emulate that person… to pay it forward,” expressed Ms. Zuniga. “I’m very thankful to be in an environment that cultivates compassion and kindness.”

Carolyn Bayabos, a Tender Operations Specialist and relatively new in MSD, conveyed the same appreciation for MSD. In 2020, her nephew underwent a critical surgery. In 2021, she tested positive for Covid-19. Through it all, her manager and MSD leaders showed compassion and empathy by allowing her to take time off and attend to her personal needs.

“They are not just concerned about my work and output,” emphasized Ms. Bayabos. “They genuinely care about me and my family. The company understands what I’m going through. I truly appreciate the support of my colleagues and MSD. It gave me hope and allowed me to carry on.”

MSD aims to provide the best health care solutions to patients. The same applies to their employees. MSD walks the talk in ensuring that their employees also have access to the best healthcare benefits. “If not for MSD, I will not have the best treatment option for cancer. When you work for a company that relates to your situation, not just as an employee, but as a person, as a woman, as a mother, your determination to stay is heightened,” shared Ms. Cordial who is a breast cancer survivor. “I am grateful for MSD’s support that has allowed me to enjoy this second life.”

Empathy brings innovation

For more than 100 years globally, and for over 25 years in the Philippines, MSD has been an innovator in the health care industry. While scientific and technical expertise are required to pursue medical breakthroughs, MSD credits empathy for driving innovation.

“Every great innovation has come from a place of empathy. Empathy is the core of an innovation culture. Without it, we are unable to create anything truly new,” said Mr. Blanch.

MSD continues to innovate across all major therapeutic areas. Mr. Blanch cites two examples—in vaccines and oncology.

To ensure equitable access to life-saving vaccines, the company partnered with government and nongovernmental organizations to build sustainable and effective vaccination delivery programs that reliably reach people. Among their landmark initiatives are “Bakunado si Lolo at Lola, Iwas Pulmonya”, a campaign that aims to educate senior citizens and caregivers on the value of immunization; “Back to BakUNA”, a school-based immunization (SBI) that underscores the safety and efficacy of vaccines and its crucial role in disease prevention, and “Sa Aking Paglaki, Walang HPV”, a program which helped introduce HPV vaccination as part of the SBI Program in LGUs.

In the area of Oncology, MSD spearheads Hope from Within, a multi-stakeholder cancer advocacy, that aims to renew hope that cancer need not be a death sentence anymore by promoting early detection of cancer, increasing access to cancer care, and spread knowledge of innovative treatment options that improve survivorship. In terms of cancer treatment, MSD worked closely with patient advocates to push forward the landmark National Integrated Cancer Control Act.

“MSD is committed to delivering breakthrough innovations to extend and improve the lives of people with cancer worldwide,” emphasized Mr. Blanch.

Empathy delivers progress

Empathetic leaders realize that the bottom line of any business is only reached through and with people. Therefore, they have an attitude of openness towards and understanding of the feelings and emotions of their team members.

“When we meet as a leadership team, we ask, what can we do to address our employees’ concerns, and how will we implement these initiatives?” We take a top-down and bottom-up approach, so it allows us to understand employees’ concern and this process is very fluid,” remarked Ms. de Vera. “It’s difficult to lead when you don’t know the pulse of the employees.”

By learning about the needs of their employees, leaders are better equipped to enable a culture of innovation and high performance.

“The reason why the leadership has a strong sense of listening to people we work with is because of empathy. We want to fully understand what our customers, what our employees are feeling. That’s the only way to come up with innovative approaches, innovative medicines. The only way for employees to trust you is through listening to them,” commented Mr. Blanch.

By prioritizing the well-being of its people, MSD, with its empowered employees, continues to serve the Filipino patients amidst the pandemic, and is well-positioned to continue innovating and delivering progress for health care, in the years to come.

The coronavirus pandemic has challenged nearly everything about healthcare delivery, especially the experiences of patients and their families.

Although the methods of delivery have changed as hospitals and doctors pivoted to virtual care, the universal commitment to patient-centered healthcare should not.

This was emphasized by Dr. Beaver Tamesis in a one-on-one Zoom interview withThe STAR.

According to the amiable doctor, a medical practitioner’s commitment to deliver on the promise of patient centeredness should not waver — especially in the midst of the pandemic.

“It’s important for patients to be in complete control when it comes to making decisions about their own health, care and treatment,” says Dr. Tamesis. “And as medical practitioners, our patients’ welfare comes first. It’s our duty to inform (them about their illness and the available treatments available in the market), advise and support them every step of the way.”

Medical practitioners must always put patients’ welfare first.

A cardiologist by training, Dr. Tamesis joined an international pharmaceutical company in 1995 hoping that his passion for healing people could help not only the firm in its business of selling products that heal, “but the Filipino nation who could benefit from them.”

“I am and will always be a doctor by heart,” he says with an impish grin.

Yes, Dr. Tamesis may not be out there in his PPE trying to save someone’s life, but many lives have been impacted through the decisions, policies and programs he has implemented since he assumed the country leadership of Merck Sharpe and Dohme (MSD) in the Philippines in 2013.

“Working for an organization as big as MSD has allowed me to take on bigger challenges and to reshape paradigms,” shares Dr. Tamesis. “We are committed to the Filipino patient.”

Upholding the company’scommitment to continue “inventing for life,” Dr. Tamesis helps steer the company in pushing for innovations to provide accessible quality healthcare among Filipinos, especially in the midst of a global pandemic.

“Every day, our vaccines — for pneumonia and HPV — and medicines save and touch lives,” he enthuses.

Cancer advocacy

During the COVID-19 outbreak, hospitals were busy attending to COVID-19 patients, leaving those that needed other forms of medical care (like cancer) on the backburner.

Cognizant of the fact that cancer remains one of the greatest healthcare challenges for Filipinos, MSD in the Philippines, through its cancer advocacy campaign Hope from Within, took the initiative to inform and remind the public that, with or without the pandemic, cancer care — most importantly access to proper information and quality care — should continue to be prioritized.

This is simply because the moment a cancer patient stops treatment, the chances of getting the virus are higher because his/her immune system is already compromised.

If implemented right and funded properly, the National Integrated Cancer Control Act will give better support to cancer patients — from diagnosis, to getting access to treatment options, to getting post-cancer care.

“We also hold a series of discussions on cancer care to inform/remind the patients and public on the importance of early diagnosis and the continuum of care,” adds. Dr. Tamesis.

Dr. Beaver Tamesis, president and managing director, MSD in the Philippines

An initiative of Hope from Within, a multi-stakeholder cancer advocacy campaign spearheaded by MSD in the Philippines, “Tita Hope Talks” gathers experts and stakeholders to discuss their perspective and provide insights on various issues surrounding cancer care. It is hosted by broadcast journalist and health advocate Niña Corpus.

“Through this, we make sure that cancer patients and their families are aware of all the new cancer treatments available in the market,” adds Dr. Tamesis. “It’s important that we get people to recognize that there are ways to get treatment, there are ways to avoid the nasty side effects of the more common or older cancer drugs and, at the same time, there are ways to find the financing for this particular treatment.”

While the cost of healthcare in the country remains a top concern for a great number of Filipinos, “Tita Hope Talks” sheds light on the continuous progress in providing Filipino patients better access to cancer care.

The signing of the Republic Act No. 11215, otherwise known as the National Integrated Cancer Control Act (NICCA), aims to augment cancer survival by strengthening essential programs throughout the whole cancer care scope.

“Getting this NICCA Law funded properly is also part of ouradvocacy,” shares Dr. Tamesis. “Hopefully, we get that similar snowball effect as when we first got the NICCA Law passed in 2019.”

If implemented right and funded properly, the NICCA will give better support to cancer patients — from diagnosis, to getting access to treatment options, to getting post cancer care.

Vaccines save lives

Before this pandemic, there were more than 100 infectious diseases to think about. But right now, there seems to be only one disease — COVID-19. Everyone avoids going to the hospital to get medical attention for fear of contracting the dreaded virus.

“And because of that, the pandemic has also slowed down government’s immunization programs for kids,” notes Dr. Tamesis. “Moms were very afraid to bring their kids tobarangayhealth centers for fear of contracting COVID-19. Fortunately, the pediatric group of doctors working with us fully agree that we have to continue the immunization programs.”

Dialogues with mommy groups were also held just to reiterate that vaccination efforts shouldn’t stop because of COVID.

“We continue to get the LGUs and doctors’ commitment to vaccinate kids against HPV and cervical cancer; and thelolosandlolasagainst pneumonia.”

An oral pill for COVID-19?

With the pandemic thrusting healthcare into the spotlight, MSD is contributing towards finding a solution for COVID-19. In fact, it recently announced the clinical trial of Molnupiravir, an antiviral pill that is being evaluated for treatment of COVID-19. 

Molnupiravir is an antiviral pill that is being evaluated for treatment of COVID-19.

“Molnupiravir is being developed by MSD in collaboration with Ridgeback Biotherapeutics,” shares Dr. Tamesis. “Its mechanism of action is to insert itself into the SARS-COVID-2 virus. And so, when a patient is given Molnupiravir early in the course of the disease, it can kill the virus within five days.” And patients could potentially reduce the risk of developing complications and undergoing hospitalization.

A clinical trial for Molnupiravir is currently underway to find out if it’s effective or safe as a treatment for patients with mild to moderate COVID-19 without the need for hospitalization.